Status:
UNKNOWN
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
Lead Sponsor:
Community Cancer Care
Collaborating Sponsors:
Amgen
Conditions:
Cancer
Solid Tumor
Eligibility:
All Genders
18+ years
Brief Summary
The primary research objective of this protocol is to evaluate the impact of integrating a home-based symptom monitoring system in the day-to-day care of cancer patients in community settings on the f...
Detailed Description
Patients will be randomly assigned to one of two groups. One group will be offered an Internet assisted home-based symptom reporting system Cancer Symptom Monitor (CSM) for a twelve-month study period...
Eligibility Criteria
Inclusion
- 18 years old or older Diagnosis of solid tumor or hematologic malignancy Starting active treatment (chemotherapy or hormonal therapy) Must be able to give informed consent \& consent to use the Cancer Symptom Monitor -
Exclusion
- Inability to give informed consent Life expectancy of less than 3 months Subject has any kind of disorder that compromises the ability of the subject to give written informed consent and/or to comply with study procedures.
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00300001
Start Date
March 1 2006
Last Update
August 25 2006
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Quality Oncology Care, Inc.
Indianapolis, Indiana, United States, 46202
2
Community Regional Cancer Center-Community Hospital North
Indianapolis, Indiana, United States, 46256
3
Morgan Hospital and Medical Center
Martinsville, Indiana, United States, 46151